Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 7 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 321 sh | Jan 16, 2026 |
| 6 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $126K 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 6 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $126K 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 6 | Sumner CrystalSee Remarks | Open-market sale · 10b5-1 plan | SELL | $22K 5,055 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Tariq MusaDirector | Option exercise | M | — 250 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Wold Dyan Z.VP, Controller and CAO | Tax withholding | F | $487 5 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Winn Caroline AnnExecutive Vice President | Tax withholding | F | $1,510 16 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Sedgwick Karen LExecutive VP and CFO | Tax withholding | F | $568 6 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Murphy Scott MChief Accounting Officer | Tax withholding | F | $5,400 406 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Yates Daniel S.SVP, Chief Accounting Officer | Tax withholding | F | $18K 459 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Larroque Alexander LisaSVP, Corp Affairs and HR | Tax withholding | F | $923 10 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $286K 7,046 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $448K 10.7K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $383K 9,258 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $479K 11.5K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $348K 8,467 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $533K 13.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 3 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 2,813 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 3 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Grant or award · 10b5-1 plan | A | — 37.2K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 2 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $68K 14.6K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 2 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $93K 5,893 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 1 | Peer AndrewVP, Corporate Controller & CAO | Open-market sale · 10b5-1 plan | SELL | $15K 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Peer AndrewVP, Corporate Controller & CAO | Option exercise · 10b5-1 plan | M | $4,270 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | — 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Inukonda RaviCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | — 1,017 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 2,678 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Peer AndrewVP, Corporate Controller & CAO | Option exercise · 10b5-1 plan | M | — 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $25K 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Inukonda RaviCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | $7,790 1,017 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $2,446 321 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |